Pharma Stocks
-
The First Commercial Operating System for Pharma, Powered by Semmelweis
Built by 75. Proven by 5. Launched to the industry. Daily Command orchestrates the entire commercialization journey — physician awareness…
Read More » -
Donald Trump’s Drug-Pricing Deals Are Reshaping Big Pharma — Here’s What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
Drug pricing has been hanging over the pharmaceutical industry for years, and the Trump administration didn’t eliminate that pressure. It…
Read More » -
FRE) Advances on Product Development Momentum
Key Highlights: • Firebrick Pharma shares climbed 7.14% to AUD 0.03 during the session.• Trading turnover reached approximately AUD 9,196.•…
Read More » -
Does Vertex’s Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
Key Points Vertex is buying Crinetics Pharmaceuticals for $10 billion. The acquisition could add up to $5 billion in revenue.…
Read More » -
Zealand Pharma – Transactions related to share buy-back program (week 28, 2026)
Zealand Pharma Company announcement No. 32 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 28, 2026)…
Read More » -
Vertex Pharma stock holds steady as cystic fibrosis franchise underpins long-term growth outlook
Vertex Pharma stock represents one of the more established names in US biotechnology, built on a dominant position in cystic…
Read More » -
Analysts Are Updating Their Mankind Pharma Limited (NSE:MANKIND) Estimates After Its Yearly Results
The yearly results for Mankind Pharma Limited (NSE:MANKIND) were released last week, making it a good time to revisit its…
Read More » -
Pfizer (NYSE:PFE) scores FDA approval but Wall Street reaction muted
New York, July 12, 2026, 17:19 (EDT) U.S. markets are shut for the weekend, so investors are waiting to see…
Read More » -
BridgeBio Pharma (BBIO) Following Wainua Trial Setback Still Looks Undervalued
BridgeBio Pharma (BBIO) stock recently moved after AstraZeneca reported that its CARDIO-TTRansform trial of Wainua in ATTR-CM did not meet…
Read More » -
Ascendis Pharma (ASND) Stock Looks Above Fair Value As Shares Jump 24%
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for FREE. Ascendis…
Read More »